# Phase 3 brain cancer trials recruiting: 22 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 22 trials in phase 3 for brain cancer that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 3 brain cancer trials: 22 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-3/brain-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 22
- Recruiting or not yet: 22
- Read on: November 19, 2026

## Trials

The 22 newest of 22, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 12, 2026 | NCT07931261 | \[18F\]FET PET for Differentiating Tumor Progression vs Treatment-Related Changes in Brain Metastases | Telix Pharmaceuticals (Innovations) Pty Limited | Phase 3 | Not yet recruiting | Brain Metastasis, Radiation Necrosis, Pseudoprogression, Tumor Progression | 381 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931261) |
| March 19, 2026 | NCT07481786 | Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases | Sun Yat-sen University | Phase 3 | Recruiting | Lung Adenocarcinoma, Brain Metastases, Radiotherapy, Intensity-Modulated, Bevacizumab, Whole-Brain Radiotherapy | 220 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07481786) |
| January 29, 2026 | NCT07376304 | Intraoperative Ultrasound for Brain Tumor Surgery Enhanced by AI | Hospital del Rio Hortega | Phase 3 | Not yet recruiting | Brain Tumor Adult | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07376304) |
| January 9, 2026 | NCT07329634 | Evaluation of Neoadjuvant Stereotactic Radiosurgery (SRS) and Multi-fraction SRS Alone for the Treatment of Large Brain Metastases | Sponsor not shown (see the record) | Phase 3 | Not yet recruiting | Brain Metastasis | 98 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07329634) |
| September 11, 2025 | NCT07167134 | Evolution of Hypofractionated Stereotactic Irradiation for Radio-Resistant Brain Metastases From D1-3-5 to D1-2-3 | Centre Paul Strauss | Phase 3 | Not yet recruiting | Brain Metastases | 264 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07167134) |
| August 3, 2025 | NCT07100730 | Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma | Telix Pharmaceuticals (Innovations) Pty Limited | Phase 3 | Recruiting | Neoplastic Disease, Glioblastoma, Glioblastoma (GBM), Glioblastoma Multiform, Glioblastoma Multiforme, Adult... | 51 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07100730) |
| April 1, 2025 | NCT06905587 | Methylphenidate in Pediatric Brain Tumor Survivors With Cancer-related Fatigue | Odense University Hospital | Phase 3 | Recruiting | Brain Tumor, Pediatric, Cancer-related Fatigue, Methylphenidate | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06905587) |
| March 21, 2025 | NCT06888817 | Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic Cerebral Radiation Necrosis After Radiation for... | The Netherlands Cancer Institute | Phase 3 | Recruiting | Radiation Necrosis, High Grade Glioma (III or IV), Brain Metastasases, Radiation Toxicity, Radiation Effect, Radiation... | 408 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06888817) |
| July 11, 2024 | NCT06496971 | A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused... | NaviFUS Corporation | Phase 3 | Recruiting | Glioblastoma Multiforme, Glioblastoma, Glioblastoma Multiforme, Adult, Glioma, Brain Tumor, Brain Tumor, Recurrent... | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06496971) |
| June 27, 2024 | NCT06477939 | Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly... | Institut de cancérologie Strasbourg Europe | Phase 3 | Not yet recruiting | Glioblastoma | 554 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06477939) |
| June 24, 2024 | NCT06471465 | Corticodependent or Corticoresistant Brain Radionecrosis After Radiotherapy for Brain Metastases | Institut Cancerologie de l'Ouest | Phase 3 | Recruiting | Radionecrosis of Brain, Brain Metastases | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06471465) |
| June 13, 2024 | NCT06457906 | SRS/SRT/Hypo-RT Versus HA-WBRT for No More Than 10 Brain Metastases in SCLC | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 3 | Recruiting | Small-cell Lung Cancer, Brain Metastases, SRS, Stereotactic Radiotherapy, Whole Brain Radiotherpay... | 340 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06457906) |
| June 4, 2024 | NCT06442748 | Short Versus Long-term Levetiracetam in Brain Tumors | Tata Memorial Centre | Phase 3 | Recruiting | Seizures, Brain Tumors, Antiepileptics, Levetiracetam | 604 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06442748) |
| January 29, 2024 | NCT06229483 | The Effects of Intraoperative Tranexamic Acid on Perioperative Bleeding In Craniotomies | Sponsor not shown (see the record) | Phase 3 | Recruiting | Brain Tumor, Bleeding | 102 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06229483) |
| December 6, 2023 | NCT06159335 | 18F-FLUC PET/MR in Patients With Brain Mets | University of Wisconsin, Madison | Phase 3 | Recruiting | Brain Metastasis, Radiation Therapy, Immunotherapy, Active | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06159335) |
| March 14, 2023 | NCT05768490 | Early or Delayed Intervention of Brain Radiotherapy Combined With Almonertinib in EGFR Mutated NSCLC With Brain Metastases | Sun Yat-sen University | Phase 3 | Recruiting | Brain Metastases, Radiotherapy, EGFR Activating Mutation | 232 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05768490) |
| April 8, 2022 | NCT05317858 | Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets | InSightec | Phase 3 | Recruiting | Brain Tumor, Non Small Cell Lung Cancer | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05317858) |
| March 8, 2022 | NCT05271240 | Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and... | Northwell Health | Phase 3 | Recruiting | Glioblastoma, Glioblastoma Multiforme, Glioma, Malignant, GBM, Brain Cancer, Glioblastoma, IDH-wildtype, Glioblastoma... | 432 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05271240) |
| January 13, 2021 | NCT04706910 | 18F-DOPA II - PET Imaging Optimization | University of Alberta | Phase 3 | Recruiting | Congenital Hyperinsulinism, Neuroblastoma, Parkinson Disease, Lewy Body Disease, Neuroendocrine Tumors, Brain Tumor | 800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04706910) |
| November 21, 2018 | NCT03750227 | Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors | Mayo Clinic | Phase 3 | Recruiting | Malignant Solid Neoplasm, Metastatic Malignant Neoplasm in the Brain | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03750227) |
| June 8, 2018 | NCT03550391 | Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain... | Canadian Cancer Trials Group | Phase 3 | Recruiting | Brain Metastases | 206 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03550391) |
| February 1, 2018 | NCT03418961 | S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity | SWOG Cancer Research Network | Phase 3 | Recruiting | Cardiotoxicity, HER2/Neu Positive, Metastatic Malignant Neoplasm in the Brain, Recurrent Breast Carcinoma, Stage IV... | 491 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03418961) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [Telix Pharmaceuticals (Innovations) Pty Limited](https://specstream.ai/data/clinical-trials/company/telix-pharmaceuticals-innovations-pty-limited) | 2 |
| Sun Yat-sen University | 2 |
| SWOG Cancer Research Network | 1 |
| Institut Cancerologie de l'Ouest | 1 |
| Institut de cancérologie Strasbourg Europe | 1 |
| NaviFUS Corporation | 1 |
| Northwell Health | 1 |
| University of Wisconsin, Madison | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Mayo Clinic | 1 |
| Canadian Cancer Trials Group | 1 |
| The Netherlands Cancer Institute | 1 |
| Odense University Hospital | 1 |
| [InSightec](https://specstream.ai/data/clinical-trials/company/insightec) | 1 |
| Centre Paul Strauss | 1 |
| Hospital del Rio Hortega | 1 |
| Tata Memorial Centre | 1 |
| University of Alberta | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 6 |
| Canada | 4 |
| France | 3 |
| China | 3 |
| South Korea | 2 |
| Netherlands | 2 |
| Puerto Rico | 1 |
| Saudi Arabia | 1 |
| Australia | 1 |
| Austria | 1 |
| Belgium | 1 |
| Taiwan | 1 |
| Denmark | 1 |
| India | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Home security companies in the United States](https://specstream.ai/data/businesses/home-security-companies/united-states)
- [Clothing companies in the United States](https://specstream.ai/data/businesses/clothing-companies/united-states)
- [Web design firms in the United States](https://specstream.ai/data/businesses/web-design-firms/united-states)
- [Polynesian restaurants in the United States](https://specstream.ai/data/businesses/polynesian-restaurants/united-states)
- [HVAC suppliers in the United States](https://specstream.ai/data/businesses/hvac-suppliers/united-states)
- [Concierge medicine practices in the United States](https://specstream.ai/data/businesses/concierge-medicine-practices/united-states)
